Eyecare giant Alcon has bought a majority stake in cell therapy start-up Aurion Biotech, replacing the company's chief executive, in the culmination of a months-long struggle for control.

Novartis’ long-awaited separation from its eye care division Alcon completed on schedule today, allowing it to focus its energies on medicinal products. Alcon’s shares made their debut on the ...

Associate Professor in the Department of Computer Science and Engineering at Santa Clara University. She received her B.S. and M.S. degrees from Beijing University of Posts and Telecommunications in ...

Summary: Yang is a massive Chinese 7-footer who scores with old-school craft, passes well, and cleans the glass. But how much his slow feet and lack of shooting range can be improved will ...

Novartis and eyecare spinout Alcon have agreed to settle bribery charges brought by the US federal authorities, focused on activities in Greece and other countries, for $347 million.

Access Alcon stock price history with daily data, historical prices, all-time highs, and stock chart history. Download and analyze trends easily.

The main portion of employees (over 60,000) worked in pharmaceuticals – the company's main focus – while the rest are split between Alcon, Sandoz, Vaccines and Diagnostics, Consumer Health ...

GENEVA, May 28, 2025--Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease ...